Optceutics Limited

Optceutics has developed the PK-Eye™, an automated high throughput ophthalmic pharmacokinetic model, designed to speed and enhance development of intra-ocular drugs and formulations. The PK-Eye™ can be used to: Identify and develop optimal intra-ocular formulation technology Facilitate selection of dose and dose frequency Compare activity and duration to existing marketed products Reduce program risk BEFORE moving into costly animal and human studies Streamline development and regulatory process for biosimilar and biobetter products Generate unique data to support additional patent coverage With a laboratory located in the former Pfizer UK research hub in Discovery Park, Optceutics works with ophthalmic drug developers worldwide through fee-for-service and risk shared strategic collaboration. Please contact us to discuss how Optceutics could support your ophthalmic drug programme.